AnalystsTessa Romero
Tessa Romero's Stock Forecasts

Sectors:
Industries:
Analyst Ranking
Top 19%
#930 out of 4928 analysts
Average Return
+13.77%
Win Rate
40%19 out of 47
Risk vs Reward
Poor
Good

Tessa Romero's 5 best and worst ratings

Name / TickerGain/LossEntry PriceExit PricePeriodRating
Scholar Rock Holding CorpSRRK
+402.83%$7.07$35.55
2024-10-03 -
2025-07-02
Strong Buy
Dyne Therapeutics IncDYN
+307.09%$10.58$43.07
2023-08-09 -
2024-08-08
Strong Buy
Biohaven LtdBHVN
+174.33%$14.65$40.19
2023-01-04 -
2024-01-03
Strong Buy
Edgewise Therapeutics IncEWTX
+132.39%$7.75$18.01
2023-06-30 -
2024-06-28
Strong Buy
Biohaven LtdBHVN
+97.54%$19.88$39.27
2023-08-16 -
2024-08-15
Strong Buy

Tessa Romero's Stock Coverage

Name / TickerNo. RatingsRatingPrice TargetUpside/DownsideActionDate
Biohaven LtdBHVN
7Strong Buy$55.00+272.63%Maintains
16 days ago
Cytokinetics IncCYTK
5Strong Buy$53.00+54.25%Maintains
25 days ago
Acadia Pharmaceuticals IncACAD
7Strong Buy$30.00+41.24%Maintains
a month ago
Lexeo Therapeutics IncLXEO
2Strong Buy$10.00+128.31%Maintains
a month ago
Dyne Therapeutics IncDYN
5Hold$17.00+90.16%Maintains
3 months ago
Upstream Bio IncUPB
1Strong Buy$38.00+241.42%Initiates Coverage On
8 months ago
Neumora Therapeutics IncNMRA
4Hold$15.00+1,818.16%Downgrades
8 months ago
Scholar Rock Holding CorpSRRK
4Strong Buy$31.00-12.80%Maintains
9 months ago
Eyepoint Pharmaceuticals IncEYPT
3Strong Buy$29.00+200.21%Maintains
a year ago
Edgewise Therapeutics IncEWTX
8Strong Buy$31.00+138.28%Maintains
a year ago
Agios Pharmaceuticals IncAGIO
6Hold$46.00N/AReinstates
a year ago
Y Mabs Therapeutics IncYMAB
5Strong Sell$7.00N/AMaintains
2 years ago
Xenon Pharmaceuticals IncXENE
2Strong Buy$55.00N/AMaintains
2 years ago
Seres Therapeutics IncMCRB
1Hold$140.00N/AInitiates Coverage On
2 years ago
Global Blood Therapeutics IncGBT
2Hold$36.00N/AMaintains
3 years ago
Orchard Therapeutics PLCORTX
1Strong Buy$150.00N/AAssumes
4 years ago
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.